BDX vs CGS

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

BDX

BCAL FPO [BDX]

58MEDIUM

CGS

COGSTATE FPO [CGS]

58MEDIUM

Score Breakdown

BDX CGS
Technical
73
47
Catalyst
63
53
Sentiment
50
50
Fundamental
47
96
Momentum
54
79
Risk Gate
50
50

Key Metrics

BDX Metric CGS
$29.9MMarket Cap$489.3M
932KAvg Volume (20d)397K
N/AShort Interest+0.1%
$0.15552-Week High$3.010
$0.05252-Week Low$1.550
+11.0%Daily Change-3.5%
$0.081Reference Price$2.780
-121.7%ROE+22.5%
-282.1%Profit Margin+19.2%

Active Signals

BDX Signals

●MACD just crossed bullish — momentum is shifting to the upside
●On a tear — up 12.5% over the last 5 days
●Beating the Small Ords index — relative strength of 1.43, so it's outpacing the pack
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Low cash runway (2 quarters) - dilution risk
●Moderate P/S ratio (11.8x)
●Revenue declining (-8%)

CGS Signals

●MACD crossed bearish — momentum is fading
●Volume surging at 2.4x normal while price falls — heavy selling pressure
●Trading above the 200-day average — the long-term trend is on your side
●Cash positive / operating cashflow positive
●Moderate P/S ratio (8.7x)
●Moderate revenue growth (+12%)
●Piotroski F-Score strong (8/9, low-confidence approx)
●EPS estimates revised upward (+10pts)

Ask Scout AI to compare BDX and CGS in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

PTX vs SPL →BDX vs SPL →BDX vs PTX →ARX vs EYE →ARX vs MVP →
BDX Full Analysis → CGS Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).